Amarin Corp. Plc (AMRN)
13.82
-0.27
(-1.92%)
USD |
NASDAQ |
Aug 24, 16:00
13.82
0.00 (0.00%)
After-Hours: 19:20
Amarin Debt to Equity Ratio : 0.0118 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0118 |
| March 31, 2026 | 0.0124 |
| December 31, 2025 | 0.0132 |
| September 30, 2025 | 0.0147 |
| June 30, 2025 | 0.0158 |
| March 31, 2025 | 0.0168 |
| December 31, 2024 | 0.0159 |
| September 30, 2024 | 0.0155 |
| June 30, 2024 | 0.0147 |
| March 31, 2024 | 0.0154 |
| December 31, 2023 | 0.0158 |
| September 30, 2023 | 0.0162 |
| June 30, 2023 | 0.0166 |
| March 31, 2023 | 0.0337 |
| December 31, 2022 | 0.0337 |
| September 30, 2022 | 0.0187 |
| June 30, 2022 | 0.0193 |
| March 31, 2022 | 0.0176 |
| December 31, 2021 | 0.0155 |
| September 30, 2021 | 0.0163 |
| June 30, 2021 | 0.0163 |
| March 31, 2021 | 0.0167 |
| December 31, 2020 | 0.0156 |
| September 30, 2020 | 0.033 |
| June 30, 2020 | 0.0545 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0804 |
| December 31, 2019 | 0.0985 |
| September 30, 2019 | 0.1169 |
| June 30, 2019 | 0.5223 |
| March 31, 2019 | 0.5915 |
| December 31, 2018 | 0.5275 |
| September 30, 2018 | -2.147 |
| June 30, 2018 | -2.507 |
| March 31, 2018 | -7.151 |
| December 31, 2017 | -1.884 |
| September 30, 2017 | -2.709 |
| June 30, 2017 | -3.288 |
| March 31, 2017 | -3.462 |
| December 31, 2016 | -12.86 |
| September 30, 2016 | 7.735 |
| June 30, 2016 | -0.7577 |
| March 31, 2016 | -1.620 |
| December 31, 2015 | -1.959 |
| September 30, 2015 | -2.143 |
| June 30, 2015 | -2.597 |
| March 31, 2015 | -1.685 |
| December 31, 2014 | -2.648 |
| September 30, 2014 | -3.357 |
| June 30, 2014 | -4.347 |
| March 31, 2014 | -4.268 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Neurocrine Biosciences, Inc. | 0.1088 |
| Cellectis SA | 2.539 |
| Alkermes Plc | 0.8695 |
| Akari Therapeutics Plc | 0.0373 |
| Liquidia Corp. | 0.9374 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 624.36M |
| Total Liabilities (Quarterly) | 180.75M |
| Shareholders Equity (Quarterly) | 443.62M |
| Current Ratio | 3.671 |
| Net Debt Paydown Yield | 0.16% |